Product Description

250 mg Gefitinib Tablet IP is medicinal formulation which is indicated for treatment of breast & lung cancers with superior effectiveness. It inhibits activation of anti-apoptotic Ras signal transduction cascade by binding to ATP-binding site of epidermal growth factor receptor. Each tablet present in pack contains 250 mg of active compound gefitinib which gets metabolized after ingestion. About 59% of drug is absorbed after consumption whereas 90% binds to proteins. 250 mg Gefitinib Tablet IP assures targeted mode of action and is available at reasonable rates in large quantities as demanded by our trusted customers. 

Product details

Minimum Order Quantity

1 Pack

Packaging Type





250 mg

Packaging Size

Strip of 10 tablets


* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Other Products in 'Cancer Treatment Tablet' category

Back to top
NEXT GEN BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.